论文部分内容阅读
淋巴细胞白血病是一类具有不同临床特征和预后的异质性疾病。1980年以来,国外较普遍采用了针对淋巴细胞表面分化标志的单克隆抗体(McAb)进行免疫分型,能较精确显示不同类型白血病细胞具有不同分化阶段的表型
Lymphocytic leukemia is a heterogeneous group of diseases with different clinical characteristics and prognosis. Since 1980, the monoclonal antibody (McAb) against lymphocyte surface differentiation has been widely used in foreign countries for immunophenotyping, which can more accurately show the phenotype of different types of leukemia cells with different differentiation stages